Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bullish
Daily trend turns up above $10.48
Key levels
Resistance$2.83
Resistance$2.63
Support$2.29
Support$2.09
Latest news & SEC filings
No headlines in the last 90 days.
Protara Therapeutics is a New York City-based drug developer focused on cancer and uncommon diseases. Its main candidate, TARA-002, is a cell-based therapy in testing for bladder cancer that has not invaded muscle and for lymphatic malformations, mostly in children. A second program, IV Choline Chloride, is being studied as a choline replacement for people who rely on intravenous nutrition and fluids. The company's activities are centered in the United States, with rights to TARA-002 everywhere except Japan and Taiwan.
Based on the company's 10-K filed Mar 10, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TARA.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$6.43
12
Moat Score
NONE
2/9
Piotroski Score
2.4
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| CONKLING WILLIAM | officer | Sale | 6,008 | $26K | Jun 2, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
38.25%
FCF Growth YoY
-57.4%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for TARA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:08:06 | $2.63 | 1,000 | $$3K | BUY |
| 21:02:18 | $2.62 | 4,531 | $$12K | SELL |
| 21:00:01 | $2.62 | 2,100 | $$6K | SELL |
| 20:59:56 | $2.63 | 1,000 | $$3K | MIDPOINT |
| 20:59:38 | $2.62 | 1,000 | $$3K | BUY |
5 dark pool trades shown · $$25K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for TARA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $5 | Feb 19 | 100 | $$50 | 5 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$60 | 6 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$10 | 1 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$310 | 31 | SWEEP |
| CALL | $5 | Feb 19 | 100 | $$50 | 5 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Protara Therapeutics, Inc. (TARA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Protara Therapeutics, Inc. (TARA) is at $2.62, up 7.82% (+$0.19) at the Nov 11, 2026 close.
Analyst ratings for TARA: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
TARA last reported on Aug 11, 2026: EPS -$0.36 vs -$0.33 expected — a miss of 10.5%.
TARA does not currently pay a dividend.
Support: $2.29, $2.09, $1.78. Resistance: $2.63, $2.83, $3.05.
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.